Yang Sung-Sen, Morimoto Tetsuji, Rai Tatemitsu, Chiga Motoko, Sohara Eisei, Ohno Mayuko, Uchida Keiko, Lin Shih-Hua, Moriguchi Tetsuo, Shibuya Hiroshi, Kondo Yoshiaki, Sasaki Sei, Uchida Shinichi
Department of Nephrology, Graduate School of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8519, Japan.
Cell Metab. 2007 May;5(5):331-44. doi: 10.1016/j.cmet.2007.03.009.
WNK1 and WNK4 mutations have been reported to cause pseudohypoaldosteronism type II (PHAII), an autosomal-dominant disorder characterized by hyperkalemia and hypertension. To elucidate the molecular pathophysiology of PHAII, we generated Wnk4(D561A/+) knockin mice presenting the phenotypes of PHAII. The knockin mice showed increased apical expression of phosphorylated Na-Cl cotransporter (NCC) in the distal convoluted tubules. Increased phosphorylation of the kinases OSR1 and SPAK was also observed in the knockin mice. Apical localization of the ROMK potassium channel and transepithelial Cl(-) permeability in the cortical collecting ducts were not affected in the knockin mice, whereas activity of epithelial Na(+) channels (ENaC) was increased. This increase, however, was not evident after hydrochlorothiazide treatment, suggesting that the regulation of ENaC was not a genetic but a secondary effect. Thus, the pathogenesis of PHAII caused by a missense mutation of WNK4 was identified to be increased function of NCC through activation of the OSR1/SPAK-NCC phosphorylation cascade.
据报道,WNK1和WNK4突变可导致II型假性醛固酮减少症(PHAII),这是一种常染色体显性疾病,其特征为高钾血症和高血压。为了阐明PHAII的分子病理生理学,我们构建了呈现PHAII表型的Wnk4(D561A / +)基因敲入小鼠。基因敲入小鼠在远曲小管中显示出磷酸化钠氯共转运体(NCC)的顶端表达增加。在基因敲入小鼠中还观察到激酶OSR1和SPAK的磷酸化增加。基因敲入小鼠中ROMK钾通道的顶端定位和皮质集合管中的跨上皮Cl(-)通透性未受影响,而上皮钠通道(ENaC)的活性增加。然而,在氢氯噻嗪治疗后这种增加并不明显,这表明ENaC的调节不是遗传效应而是继发效应。因此,由WNK4错义突变引起的PHAII的发病机制被确定为通过激活OSR1 / SPAK - NCC磷酸化级联反应增加NCC的功能。